Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medigen Biotechnology Corporation (3176) Income Statement

Medigen Biotechnology Corporation Income Statement

Last quarter (Q2 2026), Medigen Biotechnology Corporation's total revenue was NT$286.02M, a decrease of 20.72% from the same quarter last year. In Q2, Medigen Biotechnology Corporation's net income was NT$-25.98M. See Medigen Biotechnology Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.58BNT$ 1.37BNT$ 1.16BNT$ 1.06BNT$ 3.92B
NT$ 857.73MNT$ 753.76MNT$ 617.33MNT$ 73.07MNT$ 2.53B
NT$ 1.01BNT$ 964.48MNT$ 1.85BNT$ 1.74BNT$ 1.75B
Depreciation and AmortizationNT$ 175.64MNT$ 175.24MNT$ 178.38MNT$ 191.65MNT$ 198.43M
NT$ 18.64MNT$ 98.91MNT$ -1.04BNT$ -1.64BNT$ 1.35B
NT$ -156.99MNT$ -210.72MNT$ -1.23BNT$ -1.67BNT$ 789.20M
NT$ -61.61MNT$ 104.48MNT$ -45.77MNT$ -205.64MNT$ 347.23M
NT$ -218.60MNT$ -112.72MNT$ -1.28BNT$ -1.61BNT$ 1.24B
NT$ -108.80MNT$ -204.69MNT$ -561.30MNT$ -675.87MNT$ -52.61M
Per Share Metrics
Basic EPSNT$ -0.78NT$ -1.47NT$ -4.03NT$ -4.86NT$ -0.38
Diluted EPSNT$ -0.78NT$ -1.47NT$ -4.03NT$ -4.86NT$ -0.38
Weighted Average Shares Outstanding139.49M139.31M139.35M139.13M138.97M
Weighted Average Shares Outstanding (Diluted)139.49M139.31M139.35M139.13M138.97M

Currency in TWD

Medigen Biotechnology Corporation Earnings and Revenue History

-2.5B02.5B5B-120 %-80 %-40 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin